Select Page
Event info
Date:18 Jun
Time:8:30 - 11:00
Venue:Medicon Valley Alliance, Copenhagen S

Good Morning Meeting – Biomarkers analysis challenges in Clinical Trials

Welcome to MVA’s Good Morning Meeting on “Biomarkers analysis challenges in Clinical Trials” with HalioDx.

One of the biggest challenges in immunotherapy area is to find accurately which patients will benefit from a therapy or a combination of therapies. To help drug developers getting this information, the assessment of biomarkers through clinical research studies represent a key step.

Date: Tuesday June 18th 2019
Time: 8:30 – 11:00
Venue: Medicon Valley Alliance, Arne Jacobsens Allé 15, 2300 Copenhagen S, Danmark – Ground floor



8:30 – 9:00

Registration & Coffee

9:00 – 9:15

Aurélie Fugon, Associate Director BD, HalioDx

9:15 – 9:45

Evaluation of immune responses in clinical phase I/II trials in tumors treated with the oncolytic peptide LTX-315
Vibeke Sundvold Gjerstad, Translational Scientist, Lytix Biopharma

9:45 – 10:15

Immunogram proof of concept
Jacques Fieschi, PhD, Senior Director R&D, HalioDx

10:15 – 10:30

Q&A session

10:30 – 11:00



Vibeke Sundvold Gjerstad
Translational Scientist
Lytix Biopharma
  Jacques Fieschi, PhD
Senior Director R&D


Arranged by:

In collaboration with: